H
Hepion Pharmaceuticals D
D
HEPA
0.16830
USD
-0.02
(-10.95%)
مغلق
حجم التداول
23,161
الربح لكل سهم
-11
العائد الربحي
-
P/E
-0
حجم السوق
1,787,255
المقالات
العنوان: Hepion Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.